Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.

Click to view the official SEC document.

Click to view the official SEC document.

Lantern Pharma (LTRN) received a USPTO Notice of Allowance for a U.S. patent on LP‑284 treatment methods for mantle cell lymphoma (MCL), double‑hit lymphoma (DHL), and other blood cancers, with expected protection into 2042 once issued.The allowed claims cover LP‑284 as a monotherapy and in combination with specified anti‑cancer agents, and include intravenous and intraperitoneal administration routes. This method‑of‑treatment patent will layer on top of existing LP‑284 composition‑of‑matter patents that protect the drug into 2039 across major markets including the United States, European Union, Japan, China, India, Mexico, Korea, and Australia. LP‑284 holds three FDA Orphan Drug Designations and is in an ongoing Phase 1a trial (NCT06132503) in relapsed or refractory B‑cell non‑Hodgkin's lymphomas and solid tumors, supported by preclinical potency data and an estimated $4 billion annual global blood cancer market opportunity.

Two identical sessions at 8:30 a.m. and 4:30 p.m. ET include a live walkthrough and open Q&A, marking withZeta.ai's first unrestricted public showing.

As we move into 2026, we are positioning to advance multiple high-value clinical programs, expand our RADR ® platform’ s commercial reach and revenue potential globally through our new AI Center of Excellence in India and strengthen our balance sheet.”. On average, our newly developed drug programs have been advanced from initial AI insights to...

DALLAS, May 12, 2025--Lantern Pharma Inc. (Nasdaq: LTRN), an artificial intelligence company developing targeted and transformative cancer therapies using its proprietary AI platform, RADR®, today ann...

President Biden's recent executive order on artificial intelligence addresses a wide array of concerns about the nascent technology: risks to national security, the use of deceptive AI-generated…

【Sci Adv】<AbstractText>The neural mechanisms coordinating social behavior and attentional control are often disrupted together ...

Using AI to find stock market opportunities. Click to read StockQuakes, by StockQuakes Team, a Substack publication with hundreds of subscribers.

INTRODUCTION Over the past two decades, technological developments have ushered in extreme levels of workplace monitoring and surveillance across many sectors. These automated systems record and quant...

This systematic analysis of everyday life inside a tech startup dissects the logic of venture capital and its consequences for entrepreneurs, workers, and societies. In recent years, dreams about our ...

Prepared testimony by Annette Bernhardt, presented at “California at the Forefront: Steering AI Towards Ethical Horizons,” Joint Informational Hearing by the CA Senate Governmental Organization Commit...

If the last year has proven anything, it is that labor is on the march. Workers across industries are fighting for economic justice in the…

YouTube video by Flavio Leccese